Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2026-02-26 @ 3:30 AM
Study NCT ID:
NCT02546934
Status:
COMPLETED
Last Update Posted:
2022-04-22
First Post:
2015-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2020-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-10
First Submit QC Date:
None
Study First Post Date:
2015-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-20
Last Update Post Date:
2022-04-22
Last Update Post Date Type:
ACTUAL